Medicamen Biotech Limited - Asset Resilience Ratio

Latest as of March 2025: 0.99%

Medicamen Biotech Limited (MEDICAMEQ) has an Asset Resilience Ratio of 0.99% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medicamen Biotech Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs29.49 Million

≈ $318.96K USD Cash + Short-term Investments

Total Assets

Rs2.97 Billion

≈ $32.11 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Medicamen Biotech Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MEDICAMEQ current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Medicamen Biotech Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read MEDICAMEQ total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs29.49 Million	0.99%
Total Liquid Assets	Rs29.49 Million	0.99%

Asset Resilience Insights

Limited Liquidity: Medicamen Biotech Limited maintains only 0.99% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Medicamen Biotech Limited Industry Peers by Asset Resilience Ratio

Compare Medicamen Biotech Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Medicamen Biotech Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Medicamen Biotech Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.99%	Rs29.49 Million ≈ $318.96K	Rs2.97 Billion ≈ $32.11 Million	-3.73pp
2024-03-31	4.73%	Rs139.20 Million ≈ $1.51 Million	Rs2.95 Billion ≈ $31.85 Million	-1.80pp
2023-03-31	6.53%	Rs181.86 Million ≈ $1.97 Million	Rs2.79 Billion ≈ $30.12 Million	+5.21pp
2022-03-31	1.32%	Rs29.89 Million ≈ $323.25K	Rs2.26 Billion ≈ $24.41 Million	+1.31pp
2021-03-31	0.02%	Rs361.20K ≈ $3.91K	Rs1.94 Billion ≈ $20.98 Million	+0.01pp
2020-03-31	0.01%	Rs216.77K ≈ $2.34K	Rs1.81 Billion ≈ $19.61 Million	-5.08pp
2019-03-31	5.09%	Rs69.51 Million ≈ $751.77K	Rs1.37 Billion ≈ $14.77 Million	+5.03pp
2018-03-31	0.06%	Rs700.00K ≈ $7.57K	Rs1.18 Billion ≈ $12.71 Million	-0.04pp
2017-03-31	0.10%	Rs700.00K ≈ $7.57K	Rs734.01 Million ≈ $7.94 Million	+0.06pp
2016-03-31	0.03%	Rs200.00K ≈ $2.16K	Rs600.18 Million ≈ $6.49 Million	+0.00pp
2015-03-31	0.03%	Rs200.00K ≈ $2.16K	Rs686.63 Million ≈ $7.43 Million	0.00pp
2014-03-31	0.03%	Rs200.00K ≈ $2.16K	Rs645.79 Million ≈ $6.98 Million	+0.00pp
2013-03-31	0.03%	Rs200.00K ≈ $2.16K	Rs652.34 Million ≈ $7.05 Million	+0.00pp
2012-03-31	0.03%	Rs200.00K ≈ $2.16K	Rs689.07 Million ≈ $7.45 Million	-0.33pp
2008-03-31	0.36%	Rs1.85 Million ≈ $20.06K	Rs517.72 Million ≈ $5.60 Million	-0.29pp
2007-03-31	0.65%	Rs3.00 Million ≈ $32.44K	Rs464.17 Million ≈ $5.02 Million	+0.45pp
2006-03-31	0.19%	Rs652.49K ≈ $7.06K	Rs338.18 Million ≈ $3.66 Million	--

pp = percentage points

About Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic

Market Cap

$48.12 Million

Rs4.45 Billion INR

Market Cap Rank

#22136 Global

#1222 in India

Share Price

Rs328.05

Change (1 day)

-5.27%

52-Week Range

Rs219.88 - Rs415.95

All Time High

Rs1195.88